Search Within

Alison Moskowitz

Formats
  1. Meeting Abstract (196)
  2. Journal Article (126)
  3. Review (13)
  4. Research Letter (12)
  5. Editorial (5)
  6. Guidelines (4)
  7. Correspondence (2)
  8. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (359)
  2. Department of Medicine (359)
  3. Hematologic Malignancies, Division of (359)
  4. Lymphoma (359)
  5. Population Sciences Research Program (235)
  6. Survivorship Research (149)

More Groups

People
  1. Steven Horwitz (234)
  2. Andrew Zelenetz (130)
  3. Paul Hamlin (119)
  4. Ariela Noy (118)
  5. Anita Kumar (106)
  6. Maria Palomba (103)

More People

Years
  1. 2025 (11)
  2. 2024 (37)
  3. 2023 (37)
  4. 2022 (20)
  5. 2021 (36)
  6. 2020 (30)

More Years

Publications
  1. Blood (150)
  2. Hematological Oncology (23)
  3. Journal of Clinical Oncology (22)
  4. Blood Advances (15)
  5. Leukemia and Lymphoma (15)
  6. Journal of the American Academy of Dermatology (14)

More Publications

Publishers
  1. American Society of Hematology (168)
  2. Wiley Blackwell (31)
  3. American Society of Clinical Oncology (25)
  4. Elsevier Inc. (22)
  5. Taylor & Francis Group (16)
  6. Mosby Elsevier (14)

More Publishers

Results (359)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world outcomes of frontline polatuzumab and impact of frailty in older adults with newly diagnosed diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Iyengar, V.; Chicola, J.; Joseph, A.; Okwali, M.; Truong, R.; Bapodra, N.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Multicenter phase II trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in treatment-naive chronic lymphocytic leukemia: 5-Year follow up, retreatment outcomes, and Impact of MRD kinetics (ΔMRD400)
    Meeting Abstract

    Soumerai, J. D.; Dogan, A.; Seshan, V.; Flaherty, K. L.; Slupe, N.; Carter, J.; Hochberg, E.; Barnes, J. A.; Abramson, J. S.; Hamilton, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • High grade B-cell lymphoma with MYC/BCL6-rearrangements (R) may have inferior outcomes compared to BCL2-R disease
    Meeting Abstract

    Healton, S. E.; Luttwak, E.; Rivas-Delgado, A.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Hamlin, P. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Subsequent treatment and clinical outcome following induction therapy on a phase II study of oral azacitidine plus CHOP for peripheral T-cell lymphoma (PTCL)
    Meeting Abstract

    Ruan, J.; Orlando, E. H.; Moskowitz, A.; Chen, Z.; Mehta-Shah, N.; Sokol, L.; Horwitz, S.; Rutherford, S. C.; Sahni, T.; Melnick, A. M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pembrolizumab maintenance instead of autologous hematopoietic cell transplantation for patients with relapsed or refractory Hodgkin lymphoma in complete response after pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin
    Meeting Abstract

    Moskowitz, A.; Shah, G. L.; Ganesan, N.; Chang, T.; Drill, E.; Davey, T.; Hancock, H.; Munayirji, B.; Douglas, M.; Santarosa, A. M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Dual-targeted therapy with ruxolitinib plus duvelisib for T-cell lymphoma
    Meeting Abstract

    Moskowitz, A.; Ganesan, N.; Chang, T.; Davey, T.; Hancock, H.; Smith, M.; Assini, A.; Sarmasti, L.; Miller, T.; Gibaldi, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Characterization of skin response in patients with mycosis fungoides and sezary syndrome treated with mogamulizumab: A retrospective, real world cohort
    Meeting Abstract

    Christensen, R.; Stuver, R.; Dusza, S.; Epstein-Peterson, Z. D.; Ghione, P.; Horwitz, S.; Johnson, W. T.; Moskowitz, A.; Myskowski, P.; Pulitzer, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Final response and survival results from a phase II trial of pembrolizumab and entinostat in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Stuver, R.; Vardhana, S. A.; Ganesan, N.; Boardman, A. P.; Caron, P.; Chang, T.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pembrolizumab for front-line treatment of extranodal NK/T-cell lymphoma
    Meeting Abstract

    Moskowitz, A.; Advani, R. H.; Ganesan, N.; Chang, T.; Hancock, H.; Davey, T.; Miller, T.; Gibaldi, A.; Smith, M.; Assini, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Brentuximab vedotin-based regimens for older patients with newly diagnosed classical Hodgkin lymphoma - International, multi-center real-world experience
    Meeting Abstract

    Luttwak, E.; Kambhampati, S.; Drill, E.; Ganesan, N.; Hofstetter, L.; Gurion, R.; Aumann, S.; Haran, A.; Geva, M.; Panossian, M.; more...
    Blood (2024)

    Fulltext@MSK | Save